• Aucun résultat trouvé

Efficacy of bisphosphonate zoledronic acid is substantially improved by low intensity ultrasound in the treatment of breast cancer bone metastases in animals

N/A
N/A
Info
Télécharger
Protected

Academic year: 2022

Partager "Efficacy of bisphosphonate zoledronic acid is substantially improved by low intensity ultrasound in the treatment of breast cancer bone metastases in animals"

Copied!
2
0
0

Chargement.... (Voir le texte intégral maintenant)

Texte intégral

(1)

HAL Id: hal-00810708

https://hal.archives-ouvertes.fr/hal-00810708

Submitted on 23 Apr 2012

HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

Efficacy of bisphosphonate zoledronic acid is

substantially improved by low intensity ultrasound in the treatment of breast cancer bone metastases in animals

Sophie Tardoski, David Melodelima, Jacqueline Ngo, Delphine Goehrig, Philippe Clézardin

To cite this version:

Sophie Tardoski, David Melodelima, Jacqueline Ngo, Delphine Goehrig, Philippe Clézardin. Efficacy of bisphosphonate zoledronic acid is substantially improved by low intensity ultrasound in the treatment of breast cancer bone metastases in animals. Acoustics 2012, Apr 2012, Nantes, France. �hal-00810708�

(2)

Efficacy of bisphosphonate zoledronic acid is

substantially improved by low intensity ultrasound in the treatment of breast cancer bone metastases in animals

S. Tardoski

a

, D. Melodelima

a

, J. Ngo

a

, D. Goehrig

b

and P. Cl´ ezardin

b

aINSERM U1032, 151 cours albert thomas, 69424 Lyon, France

bINSERM U1033, 7 rue Guillaume Paradin, 69372 Lyon, France sophie.tardoski@inserm.fr

Proceedings of the Acoustics 2012 Nantes Conference 23-27 April 2012, Nantes, France

3387

Références

Télécharger maintenant ( PDF - 2 Page - 207.14 KB )

Documents relatifs

Effects of zoledronic acid on osteoblasts in three-dimensional culture

In this context, the hFOB spheroid culture system represents a convenient in vitro model for studying the effects of BPs on osteoblasts, and may greatly contribute to

In vivo ultrasound imaging of the bone cortex

Reconstruction of a longitudinal image of the radius obtained, (a) if the anisotropic model for the wave-speed in cortical bone (equation (1)) and the optimal values (table 2)

Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions

we show that ITGA5 in breast cancer cells mediates metastatic tumor cell colonization of the bone 96.. marrow and promotes formation of osteolytic lesions

Experiential learning approach for requirements engineering education

Our advice, in the way of formal student evaluations for experiential courses, is to measure the following: (1) course effectiveness in developing leader- ship, team, problem

Représentation des Fractions avec des Modèles d'un Ensemble Jusqu'aux Huitièmes (A)

[r]

Weekly epirubicin in the treatment of gestational breast cancer (GBC)

Pregnant women with pathologically diagnosed breast cancer who received at least one administration of single agent weekly epirubicin were retrospectively evaluated.. Patients

Faire évoluer les représentations de la mort au travers des contes, de la littérature enfantine et de la discussion philosophique au cycle primaire

Au travers de cette recherche, nous désirons observer si parler de la mort, par le biais d’une séquence didactique basée sur la littérature enfantine, les contes et

TMPRSS2-ERG fusion promotes prostate cancer metastases in bone

Given that TMPRSS2-ERG increases both the migration in vitro and the subcutaneous tumor development, we then tested whether TMPRSS2-ERG could be taking part in the bone